Skip To Content

Error

Sorry, the page you're looking for has moved or doesn't exist.

You can access content using the navigation, searching or visiting the links provided on this page.

Articles and blogs 

February 27, 2020 · Clinical Connection team
Voltaren Gel 1% (diclofenac sodium topical gel) ― a common medication in workers’ compensation and auto no-fault ― will soon transition from prescription (Rx) to over-the-counter (OTC) status, according to the U.S. Food and Drug Administration (FDA). Read more...
February 23, 2020 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more...
February 13, 2020 · Lavonya Chapman Esq RN CMSP
An unpublished version of the long-waited Section 111 mandatory insurer reporting (MIR) Civil Money Penalties (CMP) has been released and is expected to be published in the Federal Register on 02/18/2020. Read more...
February 03, 2020 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more...
January 28, 2020 · Rafael Gonzalez
Although we certainly hear a great deal about Medicare becoming increasingly more aggressive with primary payers (responsible employers, corporations, insurers, self-insured entities and third-party administrators), the federal government is also becoming just as unforgiving with beneficiaries’ attorneys. Read more...
January 16, 2020
The U.S. Food and Drug Administration (FDA) has approved a new medication to treat acute (immediate) migraine with or without aura (often described as a visual disturbance such as flashing lights) in adults. Read more...
     Next >>
Page 1 of 10